Coronary artery disease. A study of three polymorphic sites of adenosine deaminase gene

Acta Cardiologica

Volumn 69, Issue 1, 2014, Pages 39-44

  Saccucci, Patrizia ^a   Binczak Kuleta, Agnieszka ^b   Banci, Maria ^c   Krzysztalowska, Maja ^b   Dofcaci, Alessandro ^c   Safranow, Krzysztof ^b   Magrini, Andrea ^a   Loniewska, Beata ^b   Kornacewicz Jach, Zdzislawa ^b   Chlubek, Dariusz ^b   Bottini, Egidio ^a   Ciechanowicz, Andrzej ^b   Gloria Bottini, Fulvia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Valmontone Hospital   (Italy)

Author keywords

ADA; ADA polymorphic sites; CAD

Indexed keywords

ADENOSINE DEAMINASE; AGED; CORONARY ARTERY DISEASE; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; SEX FACTORS;

EID: 84893965723     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.2143/AC.69.1.3011343     Document Type: Article

References (29)

1. Barankiewicz J, Danks AM, Abushanab E, Makings L, Wiemann T, Wallis RA, Pragnacharyulu PV, Fox A, Marangos PJ. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors. J Pharmacol Exp Ther 1997; 283: 1230-1238.
2. Asakura M, Asanuma H, Kim J, Liao Y, Nakamaru K, Fujita M, Komamura K, Isomura T, Furukawa H, Tomoike H, Kitakaze M. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res 2007; 30: 781-787.
3. Safranow K, Rzeuski R, Binczak-Kuleta A, Czyzycka E, Skowronek J, Jakubowska K, Wojtarowicz A, Loniewska B, Ciechanowicz A, Kornacewicz-Jach Z, Chlubek D. ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease. Cardiology 2007; 108: 275-281.
4. Valerio D, Duyvesteyn MG, Dekker BM, Weeda G, Berkvens TM, van der Voorn L, van Ormondt H, van der Eb AJ. Adenosine deaminase: characterization and expression of a gene with a remarkable promoter. EMBO J 1985; 4: 437-443.
5. Tzall S, Ellenbogen A, Eng F, Hirschhorn R. Identintification and characterization of nine RFLPs at the adenosine deaminase (ADA) locus. Am J Hum Genet 1989; 44: 864-875.
6. Cruciani F, Bernardini L, Santolamazza P, Modiano D, Torroni A, Scozzari R. Linkage disequilibrium analysis of the human adenosine deaminase (ADA) gene provides evidence for a lack of correlation between hot spots and unequal homologous recombination. Genomics 2003; 82: 20-33.
7. Londos C, Honnor RC, Dhillon GS. cAMP dependent protein kinase and lipolysis in rat adipocytes. III. Multiple modes of insulin regulation of lipolysis and regulation of insulin responses by adenylate cyclase regulators. J Biol Chem 1985; 260: 15139-15145.
8. 6-(phenylisopropyl) adenosine. FEBS Lett 1981; 132: 121-123.
9. Vannucci SJ, Nishimura H, Satoh S, Cusham SW, Holman GD, Simpson IA. Cell surface accessibility of GLUT4 glucose transporters in insulin-stimulated rat adipose cells. Modulation by isoprenaline and adenosine. Biochem J 1992; 288: 325-330.
10. Challis RA, Budohoski L, McManus B, Newsholme EA. Effects of adenosine receptors antagonist on insulin resistance in soleus muscle from obese Zucker rats. Biochem J 1984; 21: 915-917.
11. Challis RA, Richards SJ, Budohoski L. Characterization of adenosine receptor modulating insulin action in skeletal muscle. Eur J Pharmacol 1992; 226: 121-128.
12. Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela EI, Lluis C. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 1997; 52: 283-294.
13. Franco R, Aran JM, Colomer D, Matutes E, Vives-Corrons JL. Association of adenosine deaminase with erythrocyte and platelet plasma membrane: an immunological study using light and electron microscopy. J Histochem Cytochem 1990; 38: 653-658.
14. Dong R P, Kameoka J, Hegen M, Tanaka T, Xu Y, Schossman SF, Morimoto C. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 1996; 156: 1349-1355.
15. Ciruela F, Saura C, Canela EI, Mallol J, Lluis C, Franco R. Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett 1996; 380: 219-223.
16. Hirschhorn R, Yang DR, Israni A. An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different backgrounds and apparent intragenic crossover. Ann Hum Genet 1994; 58: 1-9.
17. Spencer N, Hopkinson D, Harris H. Adenosine deaminase polymorphism in man. Ann Hum Genet 1968; 32: 9-14.
18. Gloria-Bottini F, Safranow K, Banci M, Binczak-Kuleta A, Saccucci P, Ciechanowicz A, Magrini A, Kornacewicz-Jach Z, Bottini E, Chlubek D. The association of adenosine deaminase with coronary artery disease: Effect of gender and diabetes. Health 2013; 5: 166-169.
19. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW, Rary JM. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245-1249.
20. Rohlf FJ, Sokal RR. Statistical Tables (second edition), WH Freeman and Company, New York, 1981.
21. Sokal RR, Rohlf FJ. Biometry, New York: Freeman 1981: 253-261.
22. SPSS/PC Version 5.0: SPSS Inc., Chicago 1992.
23. Hansson GK. Inflammation and immune response in atherosclerosis. Curr Atheroscler Rep 1999; 1: 150-155.
24. Ostos MA, Recalde D, Zakin MM, Scott-Algara D. Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett 2002; 519: 23-29.
25. Frostegård J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005; 25: 1776-1785.
26. Pertovaara M, Raitalia A, Juonala M, Kahonen M, Lehtimaki T, Viikari JSA, Raitakari OT, Hurme M. Autoimmunity and atherosclerosis: functional polymorphim of PTPN22 is associated with phenotypes related to the risk of atherosclerosis. The Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 2007; 147: 265-269.
27. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999; 283: 1277-1278.
28. Bullough DA, Zhang C, Montag A, Mullane KM, Young MA. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo. J Clin Invest 1994; 94: 1524-1532.
29. Hourani SM, Cusack NJ. Pharmacological receptors on blood platelets. Pharmacol Rev 1991; 43: 243-298.